A DNA-based West Nile virus replicon elicits humoral and cellular immune responses in mice

Journal of Virological Methods

Volumn 178, Issue 1-2, 2011, Pages 87-93

  Cao, Fei ^a   Li, Xiao Feng ^a   Yu, Xue Dong ^a   Deng, Yong Qiang ^a   Jiang, Tao ^a   Zhu, Qing Yu ^a   Qin, E De ^a   Qin, Cheng Feng ^a  

^a BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

Author keywords

DNA based replicon; Vaccine; West Nile virus (WNV)

Indexed keywords

DNA BASED WEST NILE VIRUS REPLICON VACCINE; DNA VACCINE; GAMMA INTERFERON; IMMUNOGLOBULIN G; NEUTRALIZING ANTIBODY; NONSTRUCTURAL PROTEIN 1 ANTIBODY; PROTEIN ANTIBODY; UNCLASSIFIED DRUG; WEST NILE VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY SPECIFICITY; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOMEGALOVIRUS; FEMALE; GENE CONSTRUCT; HUMORAL IMMUNITY; IMMUNIZATION; LYMPHOCYTE PROLIFERATION; MAMMAL CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; REPLICON; REPORTER GENE; VIRUS REPLICATION; WEST NILE FLAVIVIRUS;

ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; CELL PROLIFERATION; FEMALE; IMMUNOGLOBULIN G; INTERFERON-GAMMA; LYMPHOCYTES; MICE; MICE, INBRED BALB C; VACCINES, ATTENUATED; VIRAL NONSTRUCTURAL PROTEINS; WEST NILE VIRUS; WEST NILE VIRUS VACCINES;

CYTOMEGALOVIRUS; FLAVIVIRUS; MAMMALIA; MUS; WEST NILE VIRUS;

EID: 80955163648     PISSN: 01660934     EISSN: 18790984     Source Type: Journal    
DOI: 10.1016/j.jviromet.2011.08.018     Document Type: Article

References (38)

1. Alcaraz-Estrada S.L., Manzano M.I.M., Angel R.M.D., Levis R., Padmanabhan R. Construction of a dengue virus type 4 reporter replicon and analysis of temperature-sensitive mutations in non-structural proteins 3 and 5. J. Gen. Virol. 2010, 91:2713-2718.
2. Alvarez D.E., De Lella Ezcurra A.L., Fucito S., Gamarnik A.V. Role of RNA structures present at the 3'UTR of dengue virus on translation, RNA synthesis, and viral replication. Virology 2005, 339:200-212.
3. Chambers T.J., Hahn C.S., Galler R., Rice C.M. Flavivirus genome organization, expression, and replication. Annu. Rev. Microbiol. 1990, 44:649-688.
4. Corver J., Lenches E., Smith K., Robison R.A., Sando T., Strauss E.G., Strauss J.H. Fine mapping of a cis-acting sequence element in yellow fever virus RNA that is required for RNA replication and cyclization. J. Virol. 2003, 77:2265-2270.
5. Chu J.H., Chiang C.C., Ng M.L. Immunization of flavivirus West Nile recombinant envelope domain III protein induced specific immune response and protection against West Nile virus infection. J. Immunol. 2007, 178:2699-2705.
6. Chung K.M., Nybakken G.E., Thompson B.S., Engle M.J., Marri A., Fremont D.H., Diamond M.S. Antibodies against West Nile virus nonstructural protein NS1 prevent lethal infection through Fc gamma receptor-dependent and -independent mechanisms. J. Virol. 2006, 80:1340-1351.
7. Diamond M.S., Pierson T.C., Fremont D.H. The structural immunology of antibody protection against West Nile virus. Immunol. Rev. 2008, 225:212-225.
8. Falconar A.K. Monoclonal antibodies that bind to common epitopes on the dengue virus type 2 nonstructural-1 and envelope glycoproteins display weak neutralizing activity and differentiated responses to virulent strains: implications for pathogenesis and vaccines. Clin. Vaccine Immunol. 2008, 15:549-561.
9. Gehrke R., Ecker M., Aberle S.W., Allison S.L., Heinz F.X., Mandl C.W. Incorporation of tick-borne encephalitis virus replicons into virus-like particles by a packaging cell line. J. Virol. 2003, 77:8924-8933.
10. Hayasaka D., Yoshii K., Ueki T., Iwasaki T., Takashima I. Sub-genomic replicons of tick-borne encephalitis virus. Arch. Virol. 2004, 149:1245-1256.
11. Huang Q., Yao Q., Fan H., Xiao S., Si Y., Chen H. Development of a vaccine vector based on a subgenomic replicon of porcine reproductive and respiratory syndrome virus. J. Virol. Methods 2009, 160:22-28.
12. Johnson R.E., Beard C., Montefiori D.C., Thompson J.M., Kraus A.A., Kraus M.L., Shabman R.S., Moran T.P., Fluet M.E., Whitmore A.C., Ljungberg K. Increased immunogenicity of a DNA-launched Venezuelan equine encephalitis virus-based replicon DNA vaccine. J. Virol. 2007, 370:22-32.
13. Jones C.T., Patkar C.G., Kuhn R.J. Construction and applications of yellow fever virus replicons. Virology 2005, 331:247-259.
14. Khromykh A.A., Westaway E.G. Subgenomic replicons of the flavivirus Kunjin: construction and applications. J. Virol. 1997, 71:1497-1505.
15. Khromykh A.A., Kenney M.T., Westaway E.G. Trans-complementation of flavivirus RNA polymerase gene NS5 by using Kunjin virus replicon-expressing BHK cells. J. Virol. 1998, 72:7270-7279.
16. Li X.F., Jiang T., Yu X.D., Deng Y.Q., Zhao H., Zhu Q.Y., Qin E.D., Qin C.F. RNA elements within the 5'UTR of West Nile virus genome are critical for RNA synthesis and viral replication. J. Gen. Virol. 2010, 91:1218-1223.
17. Lieberman M.M., Clements D.E., Ogata S., Wang G., Corpuz G., Wong T., Martyak T., Gilson L., Coller B.A., Leung J., Watts D.M., Tesh R.B., Siirin M., Rosa A.T., Humphreys T., Weeks-Levy C. Preparation and immunogenic properties of a recombinant West Nile subunit vaccine. Vaccine 2007, 25:414-423.
18. Lo M.K., Tilgner M., Shi P.Y. Potential high-throughput assay for screening inhibitors of West Nile virus replication. J. Virol. 2003, 77:12901-12906.
19. Maeda J., Takagi H., Hashimoto S., Kurane I., Maeda A. A PCR-based protocol for generating West Nile virus replicons. J. Virol. Methods 2008, 148:244-252.
20. Mathew A., Kurane I., Rothman A.L., Zeng L.L., Brinton M.A., Ennis F.A. Dominant recognition by human CD8+ cytotoxic T lymphocytes of dengue virus nonstructural proteins NS3 and NS1.2a. J. Clin. Invest. 1996, 98:1684-1691.
21. Monath T.P., Liu J., Kanesa-Thasan N., Myers G.A., Nichols R., Deary A., McCarthy K., Johnson C., Ermak T., Shin S., Arroyo J., Guirakhoo F., Kennedy J.S., Ennis F.A., Green S., Bedford P. A live, attenuated recombinant West Nile virus vaccine. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:6694-6699.
22. Mosimann A.L.P., Borba L., Bordignon J., Manson P.W., Santos C.N.D. Construction and characterization of a stable subgnomic replicon system of a Brazilian dengue virus type 3 strain (BR DEN3 290-02). J. Virol. Methods 2010, 163:147-152.
23. Ng C.Y., Gu F., Phong W.Y., Chen Y.L., Lim S.P., Davidson A., Vasudevan S.G. Construction and characterization of a stable subgenomic dengue virus type 2 replicon system for antiviral compound and siRNA testing. Antiviral Res. 2007, 76:222-231.
24. Pang X., Zhang M., Dayton A.I. Development of dengue virus type 2 replicons capable of prolonged expression in host cells. BMC Microbiol. 2001, 1:18.
25. Pierson T.C., Sánchez M.D., Puffer B.A., Ahmed A.A., Geiss B.J., Valentine L.E., Altamura L.A., Diamond M.S., Doms R.W. A rapid and quantitative assay for measuring antibody-mediated neutralization of West Nile virus infection. Virology 2006, 346:53-65.
26. Posadas-Herrera G., Inoue S., Fuke I., Muraki Y., Mapua C.A., Khan A.H., Parquet M.C., Manabe S., Tanishita O., Ishikawa T., Natividad F.F., Okuno Y., Hasebe F., Morita K. Development and evaluation of a formalin-inactivated West Nile Virus vaccine (WN-VAX) for a human vaccine candidate. Vaccine 2010, 28:7939-7946.
27. Puig-Basagoiti F., Deas T.S., Ren P., Tilgner M., Ferguson D.M., Shi P.Y. High-throughput assays using a luciferase-expressing replicon, virus-like particles, and full-length virus for West Nile virus drug discovery. Antimicrob. Agents Chemother. 2005, 49:4980-4988.
28. Qing M., Liu W., Yuan Z., Gu F., Shi P.Y. A high-throughput assay using dengue-1 virus-like particles for drug discovery. Antiviral Res. 2010, 86:163-171.
29. Rattanasena P., Anraku I., Gardner J., Le T.T., Wang X.J., Khromykh A.A., Suhrbier A. Prime-boost vaccinations using recombinant flavivirus replicon and vaccinia virus vaccines: an ELISPOT analysis. Immunol. Cell Biol. 2011, 89:426-436.
30. Rossi S.L., Zhao Q., O'Donnell V.K., Mason P.W. Adaptation of West Nile virus replicons to cells in culture and use of replicon-bearing cells to probe antiviral action. Virology 2005, 331:457-470.
31. Schlesinger J.J., Brandriss M.W., Cropp C.B., Monath T.P. Protection against yellow fever in monkeys by immunization with yellow fever virus nonstructural protein NS1. J. Virol. 1986, 60:1153-1155.
32. Scholle F., Girard Y.A., Zhao Q., Higgs S., Mason P.W. Trans-packaged West Nile virus-like particles: infectious properties in vitro and in infected mosquito vectors. J. Virol. 2004, 78:11605-11614.
33. Shi P.Y., Tilgner M., Lo M.K. Construction and characterization of subgenomic replicons of New York strain of West Nile virus. Virology 2002, 296:219-233.
34. Suzuki R., de Borba L., Duarte dos Santos C.N., Mason P.W. Construction of an infectious cDNA clone for a Brazilian prototype strain of dengue virus type 1: characterization of a temperature-sensitive mutation in NS1. Virology 2007, 362:374-383.
35. Varnavski A.N., Young P.R., Khromykh A.A. Stable high-level expression of heterologous genes in vitro and in vivo by noncytopathic DNA-based Kunjin virus replicon vectors. J. Virol. 2000, 74:4394-4403.
36. Widman D.G., Ishikawa T., Giavedoni L.D., Hodara V.L., Garza M., Montalbo J.A., Rosa A.P.T., Tesh R.B., Patterson J.L., Carrion R., Bourne N., Mason P.W. Evaluation of RepliVAX WN, a single-cycle flavivirus vaccine, in a non-human primate model of West Nile virus infection. Am. J. Trop. Med. Hyg. 2010, 82:1160-1167.
37. Yoshii K., Holbrook M.R. Sub-genomic replicon and virus-like particles of Omsk hemorrhagic fever virus. Arch. Virol. 2009, 154:573-580.
38. Yun S.I., Choi Y.J., Yu X.F., Shin Y.H., Ju Y.R., Kim S.Y., Lee Y.M. Engineering the Japanese encephalitis virus RNA genome for the expression of foreign genes of various sizes: implications for packaging capacity and RNA replication efficiency. J. Neurovirol. 2007, 13:522-535.